Browsing byAuthorSomogyi, AA
Showing results 1 to 5 of 5
| Issue Date | Title | Author(s) |
| 2015-01-01 | Can variability in the effect of opioids on refractory breathlessness be explained by genetic factors? | Currow, DC; Quinn, S; Ekstrom, M; Kaasa, S; Johnson, MJ; Somogyi, AA; Klepstad, P |
| 2015-08-01 | CYP2B6∗6 allele and age substantially reduce steady-state ketamine clearance in chronic pain patients: Impact on adverse effects | Li, Y; Jackson, KA; Slon, B; Hardy, JR; Franco, M; William, L; Poon, P; Coller, JK; Hutchinson, MR; Currow, DC; Somogyi, AA |
| 2007-05-01 | Effect of CYP2D6 metabolizer status on the disposition of the (+) and (-) enantiomers of perhexiline in patients with myocardial ischaemia | Inglis, SC; Herbert, MK; Davies, BJL; Coller, JK; James, HM; Horowitz, JD; Morris, RG; Milne, RW; Somogyi, AA; Sallustio, BC |
| 2023-03 | Establishing a Longitudinal Opioid Pharmacogenomic Registry for Cancer Patients: Feasibility and Acceptability. | Philip, J; Wong, A; Pasanen, L; Somogyi, AA; Rubio, J; Klepstad, P; Collins, A; Gibbs, P; Le, B |
| 2017-07-01 | A pragmatic, phase III, multisite, double-blind, placebo-controlled, parallel-Arm, dose increment randomised trial of regular, low-dose extended-release morphine for chronic breathlessness: Breathlessness, Exertion and Morphine Sulfate (BEAMS) study protocol | Currow, D; Watts, GJ; Johnson, M; McDonald, CF; Miners, JO; Somogyi, AA; Denehy, L; McCaffrey, N; Eckert, DJ; McCloud, P; Louw, S; Lam, L; Greene, A; Fazekas, B; Clark, KC; Fong, K; Agar, MR; Joshi, R; Kilbreath, S; Ferreira, D; Ekström, M |
